Cardiovascular disease risk screening in Australia: evidence and data gaps.

Due to the imperfect nature of risk assessment and the long subclinical disease period, RCTs assessing the clinical impact of CVD risk assessment would need to be large-scale and long term to detect changes in CVD outcomes. Keywords: Risk management; Absolute risk; Surveillance EN Risk management Absolute risk Surveillance 103 105 3 02/21/23 20230215 NES 230215 Data on the expected effectiveness of a formal cardiovascular risk screening program are needed Population-based screening programs for early disease detection are important for preventing morbidity, disability, and premature death. A formal CVD risk screening program is likely to reduce the burden of CVD across the population, but we currently lack data to support this. Rather than diagnosing CVD, absolute CVD risk assessment quantifies the likelihood that an individual will experience a primary CVD event in given period of time. [Extracted from the article]